MiPNet12.23 FiberRespiration: Difference between revisions
No edit summary |
|||
Line 5: | Line 5: | ||
|year=2016-07-19 | |year=2016-07-19 | ||
|journal=Mitochondr Physiol Network | |journal=Mitochondr Physiol Network | ||
|abstract=''' | |abstract='''Lemieux H, Votion DM, Doerrier C, Gnaiger E (2007-19) Mitochondrial respiration in permeabilized fibres: Needle biopsies from horse skeletal muscle. Mitochondr Physiol Network 12.23(08 in prep):1-4.''' Β | ||
Methodological and conceptual features of | Methodological and conceptual features of High-Resolution Respirometry (HRR) are illustrated in an experiment with permeabilized fibres in the Oroboros O2k. The experiment demonstrates [http://bioblast.at/images/e/ef/MiPNet09.12_O2k-Titrations.pdf manual titrations] applied to study respiratory capacity in permeabilized fibres. Application of the [[DatLab]] software is shown for real-time data analysis (compare [[MiPNet12.09]]). The following guideline describes the [[1GM;2D;3S;4U;5Rot-]] SUIT protocol and includes a short discussion of results (see [[Votion 2012 PLoS One]]). The experiment was carried out by participants of an O2k-Workshop on HRR in December 2007 ([[MiPNet12.24 IOC44 |IOC44]]; Schroecken, Austria). | ||
:Β» Product: [[Oroboros O2k]], [[Oroboros O2k-Catalogue | O2k-Catalogue]] | :Β» Product: [[Oroboros O2k]], [[Oroboros O2k-Catalogue | O2k-Catalogue]] | ||
|mipnetlab=AT_Innsbruck_Oroboros, BE_Liege_Votion DM | |mipnetlab=AT_Innsbruck_Oroboros, BE_Liege_Votion DM | ||
Line 23: | Line 23: | ||
== SUIT protocol == | == SUIT protocol == | ||
[[File:1GM;2D;2c;3S;4U;5Rot;6Ama.jpg |right|300px|link=1GM;2D;3S;4U;5Rot-]] | [[File:1GM;2D;2c;3S;4U;5Rot;6Ama.jpg |right|300px|link=1GM;2D;3S;4U;5Rot-]] | ||
* | ::::* SUIT protocol: [[1GM;2D;3S;4U;5Rot-]] | ||
'''SUIT states:''' 1-2[[GM]] 3-4[[GMS]] 5[[S]] 6[[ROX]] | '''SUIT states:''' 1-2[[GM]] 3-4[[GMS]] 5[[S]] 6[[ROX]] | ||
Line 32: | Line 32: | ||
! Respiratory state | ! Respiratory state | ||
! Pathway control | ! Pathway control | ||
! | ! Q-junction entry through ET-Complex | ||
|- | |- | ||
| 1GM | | 1GM | ||
| [[GM]] | | [[GM]]{L} | ||
| N | | N | ||
| CI | | CI | ||
Line 42: | Line 42: | ||
|- | |- | ||
| 2D | | 2D | ||
| [[GM]] | | [[GM]]{P} | ||
| N | | N | ||
| CI | | CI | ||
Line 48: | Line 48: | ||
|- | |- | ||
| 2c | | 2c | ||
| [[GM]] | | [[GM]]{P} | ||
| N | | N | ||
| CI | | CI | ||
Line 54: | Line 54: | ||
|- | |- | ||
| 3S | | 3S | ||
| [[GMS]] | | [[GMS]]{P} | ||
| NS | | NS | ||
| CI<small>&</small>II | | CI<small>&</small>II | ||
Line 60: | Line 60: | ||
|- | |- | ||
| 4U | | 4U | ||
| [[GMS]] | | [[GMS]]{E} | ||
| NS | | NS | ||
| CI<small>&</small>II | | CI<small>&</small>II | ||
Line 66: | Line 66: | ||
|- | |- | ||
| 5Rot | | 5Rot | ||
| [[S]] | | [[S]]{E} | ||
| S | | S | ||
| CII | | CII | ||
Line 72: | Line 72: | ||
|- | |- | ||
| 6Ama | | 6Ama | ||
| ROX | | [[ROX]] | ||
|} | |} | ||
Line 79: | Line 79: | ||
Figure 1. Oxygen concentration ([ΞΌM] blue line) and oxygen flux per mg wet weight of muscle ([pmolβs<sup>-1</sup>βmg<sup>-1</sup>] red lines) in O2k chamber B, in permeabilized fibres from horse skeletal muscle with the standard titration protocol. | Figure 1. Oxygen concentration ([ΞΌM] blue line) and oxygen flux per mg wet weight of muscle ([pmolβs<sup>-1</sup>βmg<sup>-1</sup>] red lines) in O2k chamber B, in permeabilized fibres from horse skeletal muscle with the standard titration protocol. | ||
A | :::: A substrate-uncoupler-inhibitor titration (SUIT) protocol (Fig. 1) was developed for respiratory studies of permeabilized muscle fibres. The protocol aims at an assessment of physiologically relevant maxumum respiratory capacity and coupling/pathway control. | ||
Β | |||
:::#<span style="color:red"> '''LEAK state with type N substrates, N''<sub>L</sub>'':'''</span> Non-phosphorylating resting state with NADH-linked (type N) substrates glutamate&malate (GM; without adenalytes; CI-linked pathway to Q). | :::#<span style="color:red"> '''LEAK state with type N substrates, N''<sub>L</sub>'':'''</span> Non-phosphorylating resting state with NADH-linked (type N) substrates glutamate&malate (GM; without adenalytes; CI-linked pathway to Q). | ||
Line 88: | Line 86: | ||
:::#<span style="color:green">'''OXPHOS capacity with type NS substrates (CI<small>&</small>II-linked pathway to Q), NS''<sub>P</sub>'':'''</span> Respiratory stimulation by convergent electron flow through Complexes I<small>&</small>II at the Q-junction, in the coupled state after further addition of succinate (S), as an estimate of OXPHOS capacity with reconstitution of the TCA cycle ([[Gnaiger 2009 Int J Biochem Cell Biol]]). | :::#<span style="color:green">'''OXPHOS capacity with type NS substrates (CI<small>&</small>II-linked pathway to Q), NS''<sub>P</sub>'':'''</span> Respiratory stimulation by convergent electron flow through Complexes I<small>&</small>II at the Q-junction, in the coupled state after further addition of succinate (S), as an estimate of OXPHOS capacity with reconstitution of the TCA cycle ([[Gnaiger 2009 Int J Biochem Cell Biol]]). | ||
:::#<span style="color:blue">'''Electron transfer-pathway (ET-pathway) capacity with type NS substrates, NS''<sub>E</sub>'':'''</span> Uncoupling by FCCP titration (avoiding inhibition by high FCCP concentrations), as a test for limitation of OXPHOS relative to ET capacity by the phosphorylation system. | :::#<span style="color:blue">'''Electron transfer-pathway (ET-pathway) capacity with type NS substrates, NS''<sub>E</sub>'':'''</span> Uncoupling by FCCP titration (avoiding inhibition by high FCCP concentrations), as a test for limitation of OXPHOS relative to ET capacity by the phosphorylation system. | ||
:::#<span style="color:blue">'''ET capacity with type S (CII) substrate, S''<sub>E</sub>'':'''</span> ET capacity with succinate, after blocking | :::#<span style="color:blue">'''ET capacity with type S (CII) substrate, S''<sub>E</sub>'':'''</span> ET capacity with succinate, after blocking CI with rotenone. | ||
:::#'''Residual oxygen consumption (ROX)''' due to oxidative side reactions in the permeabilized fibres, estimated after addition of Antimycin A (inhibitor of | :::#'''Residual oxygen consumption (ROX)''' due to oxidative side reactions in the permeabilized fibres, estimated after addition of Antimycin A (inhibitor of CIII). | ||
== Reference == | == Reference == | ||
::::* Votion DM, Gnaiger E, Lemieux H, Mouithys-Mickalad A, Serteyn D (2012) Physical fitness and mitochondrial respiratory capacity in horse skeletal muscle. PLoS One 7: e34890. - [[Votion 2012 PLoS One |Β»Bioblast linkΒ«]] | ::::* Votion DM, Gnaiger E, Lemieux H, Mouithys-Mickalad A, Serteyn D (2012) Physical fitness and mitochondrial respiratory capacity in horse skeletal muscle. PLoS One 7: e34890. - [[Votion 2012 PLoS One |Β»Bioblast linkΒ«]] |
Revision as of 12:16, 9 January 2019
Mitochondrial respiration in permeabilized fibres: Needle biopsies from horse skeletal muscle. |
Β» Β»Versions
Oroboros (2016-07-19) Mitochondr Physiol Network
Abstract: Lemieux H, Votion DM, Doerrier C, Gnaiger E (2007-19) Mitochondrial respiration in permeabilized fibres: Needle biopsies from horse skeletal muscle. Mitochondr Physiol Network 12.23(08 in prep):1-4. Methodological and conceptual features of High-Resolution Respirometry (HRR) are illustrated in an experiment with permeabilized fibres in the Oroboros O2k. The experiment demonstrates manual titrations applied to study respiratory capacity in permeabilized fibres. Application of the DatLab software is shown for real-time data analysis (compare MiPNet12.09). The following guideline describes the 1GM;2D;3S;4U;5Rot- SUIT protocol and includes a short discussion of results (see Votion 2012 PLoS One). The experiment was carried out by participants of an O2k-Workshop on HRR in December 2007 (IOC44; Schroecken, Austria).
- Β» Product: Oroboros O2k, O2k-Catalogue
β’ O2k-Network Lab: AT_Innsbruck_Oroboros, BE_Liege_Votion DM
Labels: MiParea: Respiration, Instruments;methods
Organism: Horse
Tissue;cell: Skeletal muscle
Preparation: Permeabilized tissue
Regulation: Coupling efficiency;uncoupling, Cyt c Coupling state: LEAK, OXPHOS, ET Pathway: N, S, NS HRR: Oxygraph-2k, O2k-Protocol
O2k-Demo, O2k-Core, 1GM;2D;3S;4U;5Rot-
SUIT protocol
- SUIT protocol: 1GM;2D;3S;4U;5Rot-
SUIT states: 1-2GM 3-4GMS 5S 6ROX
Step | Respiratory state | Pathway control | Q-junction entry through ET-Complex |
---|---|---|---|
1GM | GM{L} | N | CI |
2D | GM{P} | N | CI |
2c | GM{P} | N | CI |
3S | GMS{P} | NS | CI&II |
4U | GMS{E} | NS | CI&II |
5Rot | S{E} | S | CII |
6Ama | ROX |
Figure 1. Oxygen concentration ([ΞΌM] blue line) and oxygen flux per mg wet weight of muscle ([pmolβs-1βmg-1] red lines) in O2k chamber B, in permeabilized fibres from horse skeletal muscle with the standard titration protocol.
- A substrate-uncoupler-inhibitor titration (SUIT) protocol (Fig. 1) was developed for respiratory studies of permeabilized muscle fibres. The protocol aims at an assessment of physiologically relevant maxumum respiratory capacity and coupling/pathway control.
- LEAK state with type N substrates, NL: Non-phosphorylating resting state with NADH-linked (type N) substrates glutamate&malate (GM; without adenalytes; CI-linked pathway to Q).
- OXPHOS capacity with type N substrates, NP: Respiratory capacity in the active coupled state (GM with ADP).
- Cytochrome c test for quality control: Further addition of cytochrome c yields a test for integrity of the outer mitochondrial membrane (loss of cytochrome c would be indicated by a stimulation of respiration).
- OXPHOS capacity with type NS substrates (CI&II-linked pathway to Q), NSP: Respiratory stimulation by convergent electron flow through Complexes I&II at the Q-junction, in the coupled state after further addition of succinate (S), as an estimate of OXPHOS capacity with reconstitution of the TCA cycle (Gnaiger 2009 Int J Biochem Cell Biol).
- Electron transfer-pathway (ET-pathway) capacity with type NS substrates, NSE: Uncoupling by FCCP titration (avoiding inhibition by high FCCP concentrations), as a test for limitation of OXPHOS relative to ET capacity by the phosphorylation system.
- ET capacity with type S (CII) substrate, SE: ET capacity with succinate, after blocking CI with rotenone.
- Residual oxygen consumption (ROX) due to oxidative side reactions in the permeabilized fibres, estimated after addition of Antimycin A (inhibitor of CIII).
Reference
- Votion DM, Gnaiger E, Lemieux H, Mouithys-Mickalad A, Serteyn D (2012) Physical fitness and mitochondrial respiratory capacity in horse skeletal muscle. PLoS One 7: e34890. - Β»Bioblast linkΒ«